TH-3. Graves Disease
- $2,642.11
- $353.95
- Save: 86.60%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils
Absolute Basophils
Absolute Blasts
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes
Absolute Monocytes
Absolute Myelocytes
Absolute Neutrophils
Absolute Nucleated Rbc
Absolute Promyelocytes
Band Neutrophils
Basophils
Blasts
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes
Monocytes
MPV
Myelocytes
Neutrophils
Nucleated Rbc
Platelet Count
Promyelocytes
RDW
Reactive Lymphocytes
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Hemoglobin A1c
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
% Saturation
Iron Binding Capacity
Iron, Total
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
LDL/HDL Ratio
Non HDL Cholesterol
Triglycerides
Vitamin D, 25-Oh, D2
Vitamin D, 25-Oh, D3
Vitamin D, 25-Oh, Total
Vitamin D, 25-Oh, Total
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
T3 Reverse, LC/MS/MS
Also known as: Triiodothyronine
T3, Total
Also known as: Free T3, FT3, T3 Free
T3, Free
Also known as: T4 Thyroxine Total
Free T4 Index (T7)
T4 (Thyroxine), Total
Also known as: Free T4, FT4, T4 Free
T4, Free
Thyroglobulin Antibodies
Thyroid Peroxidase
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
TSH
TSH
Also known as: B12, B12 Vitamin, Cobalamin, Cyanocobalamin, Vitamin B12 Cobalamin
Vitamin B12
Also known as: B6, B6 Vitamin, Pyridoxal, Pyridoxal Phosphate, Pyridoxal Phosphate (PLP), Vitamin B6 Pyridoxal Phosphate
Vitamin B6
The TH-3. Graves Disease panel contains 15 tests with 81 biomarkers .
Brief Description: The TH-3 Graves' Disease panel is an extensive diagnostic tool specifically designed for evaluating Graves' disease, an autoimmune disorder that often leads to hyperthyroidism. This panel combines thyroid function tests with assessments for autoimmune markers, metabolic health, and nutritional status to provide a comprehensive overview of the disease's impact on the body.
Collection Method: Blood Draw
Specimen Type: Whole Blood, Serum, and Plasma
Test Preparation: Patient should be fasting 9-12 hours prior to collection.
Patient must be restricted from alcohol and vitamins for at least 24 hours before a sample collection.
Collection should be done in the morning.
Specifc to TSH: Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks.
According to the assay manufacturer Siemens: "Samples containing fluorescein can produce falsely depressed values when tested with the Advia Centaur TSH3 Ultra assay."
When and Why the TH-3 Graves' Disease Panel May Be Ordered
Healthcare providers may order the TH-3 Graves' Disease panel for individuals exhibiting symptoms of hyperthyroidism, such as rapid heartbeat, weight loss, increased appetite, and irritability, which could suggest Graves' disease. It is also useful for monitoring the disease's progression and the effectiveness of treatments. Additionally, this panel helps in evaluating the potential complications and systemic effects associated with Graves' disease.
What the TH-3 Graves' Disease Panel Checks For
- Complete Blood Count with Differential and Platelets: Assesses the health of blood cells, which can be affected by Graves' disease and its treatments, potentially leading to conditions like anemia.
- Comprehensive Metabolic Panel: Evaluates kidney and liver function, electrolyte balance, and glucose levels, offering insights into the metabolic changes associated with hyperthyroidism.
- Hemoglobin A1c: Measures average blood glucose levels over the past 2-3 months, important for detecting diabetes or prediabetes, which can be exacerbated by hyperthyroidism.
- Iron and Total Iron Binding Capacity: Evaluates iron status, which can be altered in thyroid disorders, potentially leading to anemia.
- Lipid Panel with Ratios: Investigates cholesterol levels, which can be affected by thyroid function, with hyperthyroidism often leading to lower cholesterol levels.
- QuestAssureD Vitamin D Total with D2 and D3: Measures vitamin D levels, essential for bone health and immune function, which can be impacted by thyroid status.
- T3 Reverse, T3 Total, T3 Free: Provides a comprehensive view of the active and inactive forms of triiodothyronine, helping to assess thyroid hormone metabolism and action.
- T4 Total, T4 Free: Assesses the levels of thyroxine, providing insights into the thyroid gland's output, typically elevated in Graves' disease.
- Thyroid Peroxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb): Essential for diagnosing autoimmune thyroid diseases, where these antibodies can be elevated, indicating an autoimmune process.
- Thyroid Stimulating Hormone (TSH): A key test for thyroid function, where decreased levels are indicative of hyperthyroidism, a hallmark of Graves' disease.
- Vitamin B12 and Vitamin B6: Assess levels of these vitamins, important for neurological function and energy metabolism, which can be impacted by thyroid disease.
Getting a Deeper Understanding of Your Thyroid Health
The TH-4 Graves' Disease panel builds upon the comprehensive evaluation provided by the TH-3 panel by including additional tests for TSH Receptor Binding Antibody and Thyroid Stimulating Immunoglobulin. These tests are crucial for a more detailed assessment of Graves' disease, particularly in distinguishing it from other forms of thyroiditis and hyperthyroidism. The TH-4 panel offers a deeper insight into the autoimmune mechanisms underlying Graves' disease, making it an invaluable tool for complex cases where a nuanced understanding of the disease is necessary for effective management.
Conditions or Diseases the TH-3 Graves' Disease Panel Can Check For
The TH-3 Graves' Disease panel is designed to diagnose and manage Graves' disease by assessing thyroid function and detecting the presence of autoimmune markers. It also helps in identifying and managing potential complications such as osteoporosis, cardiovascular diseases, and diabetes, which can be associated with or exacerbated by hyperthyroidism.
Use of TH-3 Graves' Disease Panel Results by Healthcare Professionals
Healthcare professionals utilize the results of the TH-3 Graves' Disease panel to diagnose Graves' disease, assess the severity of hyperthyroidism, and evaluate the effectiveness of treatment. The comprehensive nature of the panel allows for the identification and management of complications, ensuring a holistic approach to patient care.
The TH-3 Graves' Disease panel provides a thorough assessment of Graves' disease, offering critical insights into thyroid function, autoimmune status, and the broader health impacts of thyroid dysfunction. By combining thyroid function tests with assessments for autoimmune markers, metabolic health, and nutritional status, this panel enables healthcare providers to develop targeted treatment strategies, addressing the complexities of Graves' disease and enhancing patient care.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.